Effects of a novel immunosuppressive agent, FK506, on human B cell activation
暂无分享,去创建一个
[1] N. Yoshimura,et al. Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. II. Inhibition of the production of IL-2 and gamma-IFN, but not B cell-stimulating factor 2. , 1989, Transplantation.
[2] N. Suzuki,et al. Mechanism of T cell-derived helper factor production upon stimulation with pokeweed mitogen in humans. , 1988, Clinical and experimental immunology.
[3] N. Suzuki,et al. Differential mechanism for differentiation into immunoglobulin-secreting cells in human resting B lymphocyte subsets isolated on the basis of cell density. , 1988, The Journal of clinical investigation.
[4] S. Thiru,et al. Kidney transplantation in the dog receiving FK-506. , 1987, Transplantation proceedings.
[5] F. Sakai,et al. Effect of FK-506 on human mixed lymphocyte reaction in vitro. , 1987, Transplantation proceedings.
[6] T. Starzl,et al. Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. , 1987, Transplantation proceedings.
[7] G. Suzuki,et al. Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation. , 1987, Journal of immunology.
[8] C. Wright,et al. INHIBITION OF HUMAN MONOCYTE ANTIGEN PRESENTATION, BUT NOT HLA‐DR EXPRESSION, BY CYCLOSPORINE , 1987, Transplantation.
[9] M. Okuhara,et al. FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. , 1987, The Journal of antibiotics.
[10] K. Isono,et al. Prolongation of canine renal allograft survival by treatment with FK-506. , 1987, Transplantation proceedings.
[11] L. Toledo-Pereyra,et al. Failure to preserve liver allografts for 24 hours: experimental and theoretical considerations. , 1987, Transplantation Proceedings.
[12] S. Wahl,et al. Differential regulation of colony-stimulating factors and interleukin 2 production by cyclosporin A. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[13] S. Thiru,et al. Heterotopic heart transplantation in the rat receiving FK-506. , 1987, Transplantation Proceedings.
[14] N. Suzuki,et al. Implications for the role of cognate interactions in in vitro human B cell activation by Staphylococcus aureus Cowan I and pokeweed mitogen. , 1986, The Journal of clinical investigation.
[15] E. Shevach. The effects of cyclosporin A on the immune system. , 1985, Annual review of immunology.
[16] H. Kikutani,et al. B Cell Growth and Differentiation Factors and Mechanism of B Cell Activation , 1984, Immunological reviews.
[17] A. Fauci,et al. Selective suppression of an early step in human B cell activation by cyclosporin A , 1983, The Journal of experimental medicine.
[18] G. Klaus,et al. Effects of cyclosporin A on the immune system of the mouse. I. Evidence for a direct selective effect of cyclosporin A on B cells responding to anti‐immunoglobulin antibodies , 1982, European journal of immunology.
[19] G. Klaus,et al. The effects of cyclosporin A on the immune system. , 1981, Immunology today.
[20] T. Paavonen,et al. Effect of cyclosporin A on T-dependent and T-independent immunoglobulin synthesis in vitro , 1980, Nature.
[21] J. Borel,et al. Effects of the new anti-lymphocytic peptide cyclosporin A in animals. , 1977, Immunology.
[22] E. Marčenko. Restoration of Irradiated Algae after a Period of Darkness , 1965, Nature.